NRx Pharmaceuticals is Drug Discovery in United States that focus on NRX Pharmaceuticals Inc business. Founded in 2015. They cover business area such as NRX Pharmaceuticals Inc, small molecule pharmaceutical company, novel therapeutic, central nervous system disorder, life-threaten pulmonary disease, ZYESAMI, Aviptadil, an application, COVID-relate respiratory failure, bipolar depression, patient, acute suicidal ideation, behavior.
2015
( 9 years old in 2024 )
NRX Pharmaceuticals Inc
-
1201 North Market Street
Suite111
Wilmington, DE 19801
United States
Private
NRX Pharmaceuticals Incsmall molecule pharmaceutical companynovel therapeuticcentral nervous system disorderlife-threaten pulmonary diseaseZYESAMIAviptadilan applicationCOVID-relate respiratory failurebipolar depressionpatientacute suicidal ideationbehavior
* We use standard office opening hours in near NRx Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
NRx Pharmaceuticals is Drug Discovery business from United States that founded in 2015 (9 years old in 2024), NRx Pharmaceuticals business is focusing on NRX Pharmaceuticals Inc.
NRx Pharmaceuticals headquarter office and corporate office address is located in 1201 North Market Street Suite111 Wilmington, DE 19801 United States.
NRx Pharmaceuticals was founded in United States.
In 2024, NRx Pharmaceuticals is currently focus on NRX Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "NRX Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with NRx Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
